Claris Bio | Biotech & Life Sciences | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Claris Bio

Company Overview Backed By Recent Activity Similar Companies Startup DNA

Claris Bio

Claris Bio is a late-stage therapeutics company dedicated to advancing transformative therapies for sight-threatening conditions where no or limited treatment options exist

clarisbio.com

Biotech & Life Sciences

Sector

Seed

Stage

Pharmaceutical development

Model

01Company Overview

Claris Bio is a late-stage therapeutics company dedicated to advancing transformative therapies for sight-threatening conditions where no or limited treatment options exist.

02Backed By2 investors

SVSofinnova Ventures→ACAisling Capital→

Is this your company? Claim your profile

Startup Intelligence by F4F4 Research Engine

Recent Activity

FROM Aisling Capital

Joined as a new investor in Claris Bio's $118M Series B financing to advance a treatment for limbal stem cell deficiency.

INVESTMENT·globenewswire.com

JUL 28, 2026

FROM Sofinnova Ventures

Participated in Claris Bio's $118M Series B financing supporting a planned pivotal study in LSCD.

INVESTMENT·globenewswire.com

JUL 28, 2026

04Similar Companies

CT

Cirrus Therapeutics

Biotech & Life Sciences

→

O

Ocugenix

Biotech & Life Sciences

→

TP

Tarsus Pharmaceuticals

Biotech & Life Sciences

→

H

Healome

Biotech & Life Sciences

→

S

SparingVision

Biotech & Life Sciences

→

05Startup DNA

signals

Sectors
Business Model
Technology

Quick Reference

Sector

Biotech & Life Sciences

Website

clarisbio.com

Visit clarisbio.com ↗